Tehran University of Medical Sciences

Science Communicator Platform

Share By
The Lncrnas: Innovative Multifunctional Players of Drug Resistance in Colorectal Cancer Publisher



Maghsoudi H ; Rasoulzadeh M ; Abbastabar M ; Fazilat A ; Sheikhnia F ; Azizzadeh B ; Valilo M ; Majidinia M
Authors

Source: Cancer Cell International Published:2025


Abstract

Colorectal cancer (CRC) ranks as the third most prevalent malignancy and the second leading cause of cancer-related mortality globally. Despite substantial advancements in CRC therapies over recent decades, drug resistance continues to pose a significant challenge in effective treatment. This comprehensive review investigates the role of long non-coding RNAs (lncRNAs) in the emergence of drug resistance in CRC. Specifically, we analyze the functions of lncRNAs, including HOTAIR and MALAT1, in key processes such as apoptosis, DNA damage response and repair, cancer stem cell regulation, and drug metabolism. By examining the structural and biogenetic characteristics of lncRNAs, this review elucidates their specific contributions to drug resistance. We provide novel insights into the therapeutic potential of targeting lncRNAs to mitigate drug resistance in CRC, thereby offering new perspectives on treatment strategies. Ultimately, this review highlights the clinical implications of lncRNA research, emphasizing their potential as targets for innovative therapeutic interventions in colorectal cancer. © The Author(s) 2025.
Related Docs
View other Related Docs
1. Lncrnas Roles in Chemoresistance of Cancer Cells, Current Molecular Medicine (2022)
2. Dysregulated Long Non-Coding Rnas in Colorectal Cancer: Identification and Validation Using Rna-Seq and Real-Time Reverse Transcription Polymerase Chain Reaction, Cell Journal (2024)
3. Microrna: A New Player in Response to Therapy for Colorectal Cancer, Journal of Cellular Physiology (2019)
Experts (# of related papers)
View all Related Experts
Zahra Azizi Varzaneh (1)
Leyla Sahebi (1)
Other Related Docs
4. Identification of Key Lncrnas Associated With Oxaliplatin Resistance in Colorectal Cancer Cells and Isolated Exosomes: From In-Silico Prediction to In-Vitro Validation, PLoS ONE (2024)
5. Long Non-Coding Rnas (Lncrnas); Roles in Tumorigenesis and Potentials As Biomarkers in Cancer Diagnosis, Experimental Cell Research (2022)
6. Long Non-Coding Rnas in Diagnosis, Treatment, Prognosis, and Progression of Glioma: A State-Of-The-Art Review, Frontiers in Oncology (2021)
7. Cdkn2b-As1 As a Novel Therapeutic Target in Cancer: Mechanism and Clinical Perspective, Biochemical Pharmacology (2023)
8. Candidate Prognostic Lncrnas Including C2orf49-Dt, Capn10-Dt, Loc105371795 As Potential Biomarkers for Colorectal Cancer, Biochemical Genetics (2025)
9. The Function of Novel Small Non‐Coding Rnas (Pirnas, Trfs) and Piwi Protein in Colorectal Cancer, Cancer Treatment and Research Communications (2022)
10. Long Noncoding Rnas and Exosomal Lncrnas: Classification, and Mechanisms in Breast Cancer Metastasis and Drug Resistance, Oncogene (2020)
11. Crosstalk Between Lncrnas in the Apoptotic Pathway and Therapeutic Targets in Cancer, Cytokine and Growth Factor Reviews (2022)
12. Modulation of Long Non-Coding Rnas and Micrornas by Quercetin As a Potential Therapeutical Approach in Cancer: A Comprehensive Review, Current Medicinal Chemistry (2025)
13. Cross-Talk Between Non-Coding Rnas and Pi3k/Akt/Mtor Pathway in Colorectal Cancer, Molecular Biology Reports (2021)
14. Modulation of Long Non-Coding Rnas by Resveratrol As a Potential Therapeutic Approach in Cancer: A Comprehensive Review, Pathology Research and Practice (2023)
15. Microrna-Induced Drug Resistance in Gastric Cancer, Biomedicine and Pharmacotherapy (2015)
16. Dysregulated Key Long Non-Coding Rnas Tp53tg1, Rfpl1s, Dleu1, and Hcg4 Associated With Epithelial-Mesenchymal Transition (Emt) in Castration-Resistant Prostate Cancer, Advances in Cancer Biology - Metastasis (2025)
17. Noncoding Rnas As Mechanistic Regulators and Therapeutic Modulators of Yap/Taz Signaling in Colorectal Cancer, Medical Oncology (2025)
18. Long Non-Coding Rnas As Epigenetic Regulators in Cancer, Current Pharmaceutical Design (2019)
19. Expression Analysis of Circulating Plasma Long Noncoding Rnas in Colorectal Cancer: The Relevance of Lncrnas Atb and Ccat1 As Potential Clinical Hallmarks, Journal of Cellular Physiology (2019)
20. Lncrna-Mediated Regulation of Cisplatin Response in Breast Cancer, Pathology, research and practice (2024)